Aspirin After Stroke Thrombolytic
Aspirin should NOT be given immediately after completing tPA infusion for acute ischemic stroke—wait 24 hours before starting aspirin therapy. 1
Guideline Recommendation
The 2018 AHA/ASA guidelines explicitly state that for patients treated with IV alteplase, aspirin administration is generally delayed until 24 hours later 1. This represents a Class I, Level A recommendation—the strongest evidence grade available.
The rationale is straightforward:
- Aspirin given within 24-48 hours after stroke onset improves outcomes
- However, when combined with tPA, early aspirin increases bleeding risk without additional benefit
- The 24-hour delay allows the fibrinolytic effects of alteplase to dissipate while still capturing the benefits of early antiplatelet therapy
Evidence Supporting the 24-Hour Delay
The most definitive trial (2012) directly tested this question and was stopped early for harm 2. When 300 mg IV aspirin was given within 90 minutes of starting alteplase:
- No improvement in functional outcomes (54.0% vs 57.2% favorable outcome, p=0.42)
- Significantly increased symptomatic intracranial hemorrhage (4.3% vs 1.6%, p=0.04)
- Symptomatic hemorrhage more often caused poor outcomes in the aspirin group (11 vs 1 patient, p=0.006)
This trial was terminated at 642 of 800 planned patients due to clear evidence of harm without benefit 2.
The Exception Clause
The 2018 guidelines include a narrow exception: aspirin might be considered earlier "in the presence of concomitant conditions for which such treatment given in the absence of IV alteplase is known to provide substantial benefit or withholding such treatment is known to cause substantial risk" 1.
This is an extremely limited exception—think acute coronary syndrome or high-grade symptomatic carotid stenosis—not routine practice.
Common Pitfalls to Avoid
- Do not confuse "early aspirin" (within 24-48 hours of stroke) with "immediate aspirin" (right after tPA)—the former is beneficial, the latter is harmful
- Do not use aspirin as a substitute for tPA in eligible patients—this is a Class III (No Benefit) recommendation 1
- The 2013 guidelines already established that anticoagulation within 24 hours of tPA is not recommended (Class III, Level B) 3—the same principle applies to aspirin
Practical Algorithm
After completing tPA infusion:
- Wait 24 hours before starting any antiplatelet therapy
- At 24 hours post-tPA, initiate aspirin 160-300 mg daily (the 2018 guidelines removed the specific 325 mg recommendation) 1
- For patients with contraindications to aspirin, alternative antiplatelet agents may be reasonable at the 24-hour mark
Note: Recent 2026 observational data suggesting benefit from earlier aspirin 4 contradicts the high-quality 2012 RCT 2 and should not change practice until confirmed by adequately powered randomized trials.